Sequana Medical NV (SEQUA.BR)
EUR 0.72
(3.43%)
EUR 0.72
(3.43%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -29.13 Million EUR | -3.78% |
| 2022 | -29.19 Million EUR | -26.23% |
| 2021 | -22.24 Million EUR | -26.61% |
| 2020 | -17.56 Million EUR | -27.05% |
| 2019 | -13.82 Million EUR | -6.71% |
| 2018 | -13.01 Million EUR | -72.91% |
| 2017 | -7.49 Million EUR | 45.16% |
| 2016 | -13.66 Million EUR | -20.1% |
| 2015 | -11.37 Million EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -4.72 Million EUR | 0.0% |
| 2024 Q1 | -4.72 Million EUR | 31.81% |
| 2023 Q1 | -7.63 Million EUR | 47.0% |
| 2023 Q3 | -6.93 Million EUR | 54.14% |
| 2023 Q4 | -6.93 Million EUR | 0.0% |
| 2023 Q2 | -15.11 Million EUR | -97.96% |
| 2023 FY | - EUR | -3.62% |
| 2022 Q2 | -13.06 Million EUR | -98.09% |
| 2022 Q4 | -14.4 Million EUR | -90.45% |
| 2022 FY | - EUR | -26.23% |
| 2022 Q1 | -6.59 Million EUR | 44.88% |
| 2022 Q3 | -7.56 Million EUR | 42.08% |
| 2021 Q1 | -5.71 Million EUR | 34.28% |
| 2021 FY | - EUR | -26.61% |
| 2021 Q4 | -11.96 Million EUR | -95.36% |
| 2021 Q3 | -6.12 Million EUR | 45.51% |
| 2021 Q2 | -11.23 Million EUR | -96.61% |
| 2020 Q4 | -8.69 Million EUR | -100.35% |
| 2020 Q3 | -4.34 Million EUR | 48.65% |
| 2020 Q1 | -4.39 Million EUR | 37.3% |
| 2020 Q2 | -8.45 Million EUR | -92.46% |
| 2020 FY | - EUR | -27.05% |
| 2019 FY | - EUR | -6.71% |
| 2019 Q4 | -7 Million EUR | -100.33% |
| 2019 Q3 | -3.49 Million EUR | 43.47% |
| 2019 Q2 | -6.18 Million EUR | -83.87% |
| 2019 Q1 | -3.36 Million EUR | 33.67% |
| 2018 Q4 | -5.07 Million EUR | -44.34% |
| 2018 Q2 | -2.37 Million EUR | 0.0% |
| 2018 FY | - EUR | -72.91% |
| 2018 Q1 | -2.37 Million EUR | -47.33% |
| 2018 Q3 | -3.51 Million EUR | -47.67% |
| 2017 Q4 | -1.61 Million EUR | 19.02% |
| 2017 Q3 | -1.99 Million EUR | 0.0% |
| 2017 FY | - EUR | 45.16% |
| 2016 FY | - EUR | -20.1% |
| 2015 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Affluent Medical SA | -13.34 Million EUR | -118.368% |
| Bluelinea Société Anonyme | -323.98 EUR | -8993306.074% |
| Carmat SA | -50.45 Million EUR | 42.248% |
| Diagnostic Medical Systems S.A. | -7.05 Million EUR | -312.879% |
| Euromedis Groupe | -4.43 Million EUR | -556.947% |
| Eurobio Scientific Société anonyme | 18.98 Million EUR | 253.465% |
| Ikonisys S.A. | -2.34 Million EUR | -1141.172% |
| Implanet S.A. | -5.07 Million EUR | -473.899% |
| Median Technologies SA | -19.58 Million EUR | -48.771% |
| SpineGuard SA | -3.49 Million EUR | -733.238% |
| Theraclion SA | -4.48 Million EUR | -549.326% |
| Euroapi S.A. | -155.39 Million EUR | 81.25% |
| Guerbet SA | 98.83 Million EUR | 129.479% |
| Ion Beam Applications SA | 12.53 Million EUR | 332.537% |
| Koninklijke Philips N.V. | 1.04 Billion EUR | 102.799% |